Ovidrel: Clinical Trials

8 trials of Ovidrel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 unknown. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 7, Unknown 1
Phase 21Completed 1

Follow Ovidrel: new trials by email Literature Review of Ovidrel trials Research Report on Ovidrel

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation
highly purified human chorionic gonadotropin, recombinant human chorionic gonadotropin - Infertility
Phase 3CompletedFerring Pharmaceuticals1762016-04-012019-06-26
Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)
Pergoveris®, GONAL-f®, Recombinant human chorionic gonadotrophin (r-hCG) - Infertility
Phase 3CompletedMerck KGaA, Darmstadt, Germany9392014-01-312017-08-24
Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole
Progesterone Vaginal Gel 8%, Letrozole Oral Tablet, pelvic ultrasound - Polycystic Ovary Syndrome
Phase 2 / Phase 3CompletedEastern Virginia Medical School522012-07-062018-02-26
Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
Dexamethasone, recombinant human chorionic gonadotropin (r-hCG) - PCOS
Phase 3CompletedUniversity of California, San Diego242011-08-012019-04-30
PERgoveriS In Stratified Treatment for Assisted Reproductive Technique
Gonal-f®, Pergoveris®, Recombinant human chorionic gonadotropin (r-hCG) - Assisted Reproductive Techniques, Reproductive Technology, Assisted
Phase 3CompletedMerck KGaA, Darmstadt, Germany2022011-05-312021-05-28
Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment
GnRH agonist, Control - Infertility
Phase 3UnknownUniversity of Sao Paulo252009-01-012009-07-29
Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)
recombinant human chorionic gonadotropin - Polycystic Ovary Syndrome
Phase 3CompletedUniversity of California, San Diego252007-09-012018-11-21
A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)
r-hCG, Urinary-hCG - Infertility
Phase 3CompletedMerck KGaA, Darmstadt, Germany2182003-12-012014-07-31

Conditions studied

Infertility (4)  ·  Helping Behavior (3)  ·  Polycystic Ovary Syndrome (2)  ·  Menstruation Disturbances (1)  ·  Oligomenorrhea (1)

Sponsors

Merck KGaA, Darmstadt, Germany (3)  ·  University of California, San Diego (2)  ·  Eastern Virginia Medical School (1)  ·  Ferring Pharmaceuticals (1)  ·  University of Sao Paulo (1)

Countries

United States (3)  ·  Brazil (2)  ·  Germany (2)  ·  China (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Greece (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Russia (1)  ·  Slovakia (1)  ·  United Kingdom (1)

Top investigators

Huafei Li (1)  ·  Laurel A Stadtmauer, MD, PhD (1)  ·  Paulo Serafini, PhD (1)  ·  R. Jeffery Chang, M.D. (1)  ·  Salvatore Longobardi, MD (1)

Results publications

PMID 21270326, PMID 24188875, PMID 25303490, PMID 25313914, PMID 26141305, PMID 26194884, PMID 27473350, PMID 28137754